Skip to content
naulon
Not checkedNot checked for notices yet.

Complete response of leptomeningeal carcinomatosis secondary to breast cancer

Idriss Troussier, Charles Canova, Guillaume Klausner

Breast · 2020

doi:10.1016/j.breast.2020.11.019 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Leptomeningeal carcinomatosis (LC) is an unmet medical need associated with death in 4–6 weeks without treatment, delayed by 4 months in some patients with favorable prognosis and aggressive multimodal therapy. Unfortunately, most clinical trials excluded patients with LC, and the best management remains unknown.Here we present the first report of a LC secondary to HR positive breast cancer with a complete response to CDK4/6 inhibitors abemaciclib, letrozole and hippocampal-avoidance whole-brain radiotherapy.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.